137 related articles for article (PubMed ID: 36798189)
21. Mammalian ADP-ribosyltransferases and ADP-ribosylhydrolases.
Koch-Nolte F; Kernstock S; Mueller-Dieckmann C; Weiss MS; Haag F
Front Biosci; 2008 May; 13():6716-29. PubMed ID: 18508690
[TBL] [Abstract][Full Text] [Related]
22. Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice.
Kato J; Zhu J; Liu C; Moss J
Mol Cell Biol; 2007 Aug; 27(15):5534-43. PubMed ID: 17526733
[TBL] [Abstract][Full Text] [Related]
23. Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice.
Schlossarek S; Schuermann F; Geertz B; Mearini G; Eschenhagen T; Carrier L
J Muscle Res Cell Motil; 2012 May; 33(1):5-15. PubMed ID: 22076249
[TBL] [Abstract][Full Text] [Related]
24. Structure and function of eukaryotic mono-ADP-ribosyltransferases.
Okazaki IJ; Moss J
Rev Physiol Biochem Pharmacol; 1996; 129():51-104. PubMed ID: 8898563
[TBL] [Abstract][Full Text] [Related]
25. Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1.
Meza-Carmen V; Pacheco-Rodriguez G; Kang GS; Kato J; Donati C; Zhang CY; Vichi A; Payne DM; El-Chemaly S; Stylianou M; Moss J; Vaughan M
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10454-9. PubMed ID: 21653881
[TBL] [Abstract][Full Text] [Related]
26. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
[TBL] [Abstract][Full Text] [Related]
27. Torque Loss in En-Masse Retraction of Maxillary Anterior Teeth Using Miniimplants with Force Vectors at Different Levels: 3D FEM Study.
Parashar A; Aileni KR; Rachala MR; Shashidhar NR; Mallikarjun V; Parik N
J Clin Diagn Res; 2014 Dec; 8(12):ZC77-80. PubMed ID: 25654038
[TBL] [Abstract][Full Text] [Related]
28. Role of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivo.
Puhl SL; Weeks KL; Güran A; Ranieri A; Boknik P; Kirchhefer U; Müller FU; Avkiran M
Cardiovasc Res; 2019 Mar; 115(3):519-529. PubMed ID: 30203051
[TBL] [Abstract][Full Text] [Related]
29. Identification of ADP-ribosylated peptides and ADP-ribose acceptor sites.
Rosenthal F; Hottiger MO
Front Biosci (Landmark Ed); 2014 Jun; 19(7):1041-56. PubMed ID: 24896335
[TBL] [Abstract][Full Text] [Related]
30. DNA-regulated arginine-specific mono(ADP-ribosyl)ation and de-ADP-ribosylation of endogenous acceptor proteins in human neutrophils.
Obara S; Mishima K; Yamada K; Taniguchi M; Shimoyama M
Biochem Biophys Res Commun; 1989 Aug; 163(1):452-7. PubMed ID: 2505768
[TBL] [Abstract][Full Text] [Related]
31. ADP-ribosylarginine hydrolases.
Takada T; Okazaki IJ; Moss J
Mol Cell Biochem; 1994 Sep; 138(1-2):119-22. PubMed ID: 7898453
[TBL] [Abstract][Full Text] [Related]
32. Parp1 activation in mouse embryonic fibroblasts promotes Pol beta-dependent cellular hypersensitivity to alkylation damage.
Jelezcova E; Trivedi RN; Wang XH; Tang JB; Brown AR; Goellner EM; Schamus S; Fornsaglio JL; Sobol RW
Mutat Res; 2010 Apr; 686(1-2):57-67. PubMed ID: 20096707
[TBL] [Abstract][Full Text] [Related]
33. Identification of ADP-Ribose Acceptor Sites on In Vitro Modified Proteins by Liquid Chromatography-Tandem Mass Spectrometry.
Leutert M; Bilan V; Gehrig P; Hottiger MO
Methods Mol Biol; 2017; 1608():137-148. PubMed ID: 28695508
[TBL] [Abstract][Full Text] [Related]
34. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
35. Mono-ADP-ribosylation: a reversible posttranslational modification of proteins.
Okazaki IJ; Moss J
Adv Pharmacol; 1996; 35():247-80. PubMed ID: 8920207
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and clinical features of heterozygous carriers of autosomal recessive hypercholesterolemia in Sardinia.
Filigheddu F; Quagliarini F; Campagna F; Secci T; Degortes S; Zaninello R; Argiolas G; Verna R; Pitzoi S; Frau F; Troffa C; Bulla E; Bertolini S; Glorioso N; Arca M
Atherosclerosis; 2009 Nov; 207(1):162-7. PubMed ID: 19477448
[TBL] [Abstract][Full Text] [Related]
37. Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred.
Spina R; Noto D; Barbagallo CM; Monastero R; Ingrassia V; Valenti V; Baschi R; Pipitone A; Giammanco A; La Spada MP; Misiano G; Scrimali C; Cefalù AB; Averna MR
J Clin Lipidol; 2018; 12(1):145-151. PubMed ID: 29153781
[TBL] [Abstract][Full Text] [Related]
38. Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases.
Okazaki IJ; Moss J
Annu Rev Nutr; 1999; 19():485-509. PubMed ID: 10448534
[TBL] [Abstract][Full Text] [Related]
39. Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis.
Arca M; Zuliani G; Wilund K; Campagna F; Fellin R; Bertolini S; Calandra S; Ricci G; Glorioso N; Maioli M; Pintus P; Carru C; Cossu F; Cohen J; Hobbs HH
Lancet; 2002 Mar; 359(9309):841-7. PubMed ID: 11897284
[TBL] [Abstract][Full Text] [Related]
40. PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment.
Johnson S; Karpova Y; Guo D; Ghatak A; Markov DA; Tulin AV
BMC Cancer; 2022 May; 22(1):557. PubMed ID: 35585513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
